American Society of Clinical Psychopharmacology Task Force identifies situations where discontinuation of certain psychotropic medications may be clinically indicated.
Study shows that proactive outreach by a clinical pharmacist results in safer prescribing of diabetes regimens among patients with type 2 diabetes and high hypoglycemia risk.
